Medify Solutions Ltd.

Medify Solutions Ltd. (Pink Sheets: MFYS) Announces Latest Business Developments With Oracle and Revenues

    Gateshead, England (ots/PRNewswire) - Remote Technology Company Medify Solutions (Pink Sheets: MFYS) is  delighted to announce its expansion into the European market with Oracle as  business partner, the world's largest enterprise software company. Following  the positive collaborative achievements of Medify with Oracle on the NHS project, Oracle will support Medify Solutions Ltd in its European expansion.

    Medify is going live as announced to its NHS customers on the 1st of  September 2006. There are approximately 1.4m NHS employees and circa 500 000  healthcare professionals working for the NHS.

    The first roll out site is for approximately 2500 users (US85 per customer per month for two years with an expected revenue stream of US5.1m).

    The company will float its European subsidiary on the Frankfurt Exchange,  the announcement to follow shortly. This expansion is supported, as announced  by Oracle, the world's largest enterprise software company.

    Medify does have an exclusive contract with EMIS to provide its technology to EMIS users. Currently EMIS supplies its service to 60% of the  NHS UK primary care market (circa 150 000 healthcare professionals).

    Medify has commercial activities in place in the European market justifying the impending floatation.

    Medify Press Office: press@medifysolutions.com

    Company Website: www.medifysolutions.com

    This press release was constructed in conjunction with StockTargets Inc.  http://www.stocktargets.com

    This news release contains forward-looking statements that are subject to  certain risks and uncertainties that may cause actual results to differ  materially from those projected on the basis of such forward-looking  statements. The words "estimate," "project," "intends," "expects,"  "believes," and similar expressions are intended to identify forward-looking  statements. Such forward-looking statements are made based on management's  beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbour" provisions of the Private  Securities Litigation Reform Act of 1995. For a more complete description of  these and other risk factors that may affect the future performance of Medify  Solutions Limited, see "Risk Factors" in the Company's Annual Report on Form  10-KSB and its other filings with the Securities and Exchange Commission.  Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made and the Company undertakes  no obligation to disclose any revision to these forward-looking statements to  reflect events or circumstances after the date made or to reflect the  occurrence of unanticipated events.

ots Originaltext: Medify Solutions Ltd.
Im Internet recherchierbar: http://www.presseportal.ch

Contact:
For further information: Jonathan Bryant, Group Chairman, Medify
Solutions, Tel: +44-(0)-845-034-4090, Fax: +44-(0)-1785-214474,
jbryant@medifysolutions.com/



Weitere Meldungen: Medify Solutions Ltd.

Das könnte Sie auch interessieren: